Form 4: Chimerix COO and CCO, Thomas J. Riga, Reports Stock and Option Transactions

Thomas J. Riga, COO and CCO of Chimerix, Inc., reports the acquisition of common stock and stock options, as well as the vesting of restricted stock units.

Summary

• Thomas J. Riga, the COO and CCO of Chimerix, Inc., has reported several transactions involving the company's stock.
• On January 7, 2025, Riga acquired 54,275 shares of common stock through restricted stock units (RSUs) at a price of $0.
• These RSUs will vest over four years, with approximately 13,568 shares vesting each year.
• Riga also acquired 325,000 stock options with an exercise price of $3.66, which vest over 40 months.
• Additionally, the report includes 3,226 shares acquired through the Employee Stock Purchase Plan on September 10, 2024.
• Following these transactions, Riga beneficially owns 57,501 shares of common stock and 325,000 stock options.

Sentiment

Score: 6

Explanation: The document is a routine filing of insider transactions, which is neither particularly positive nor negative. It reflects standard executive compensation practices.

Positives

• The acquisition of stock options and RSUs by a key executive like the COO and CCO can be seen as a positive sign of confidence in the company's future.
• The vesting schedule of the RSUs and stock options aligns the executive's interests with the long-term performance of the company.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the equity holdings of key executives.

Comparison to Industry Standards

• The vesting schedules for the RSUs and stock options are typical for executive compensation packages in the biotechnology industry.
• The use of both RSUs and stock options is a common practice to incentivize executives and align their interests with shareholders.
• The Employee Stock Purchase Plan is a standard benefit offered by many public companies to allow employees to purchase company stock at a discount.

Stakeholder Impact

• The transactions reported in this filing provide transparency to shareholders regarding the equity holdings of a key executive.
• The vesting schedules of the RSUs and stock options align the executive's interests with the long-term performance of the company, which is beneficial for shareholders.

Key Dates

Keywords

Chimerix, stock options, restricted stock units, insider trading, executive compensation, Form 4, equity securities, beneficial ownership, employee stock purchase plan